1427744-54-4

Basic information

• Product Name: C₂₉H₃₀F₃N₇O₈S
• Synonyms: C₂₉H₃₀F₃N₇O₈S
• CAS NO: 1427744-54-4
• Molecular Weight: 693.661
• Mol File: 1427744-54-4.mol

Chemical Properties

• CAS DataBase Reference: C₂₉H₃₀F₃N₇O₈S(CAS DataBase Reference)
• NIST Chemistry Reference: C₂₉H₃₀F₃N₇O₈S(1427744-54-4)
• EPA Substance Registry System: C₂₉H₃₀F₃N₇O₈S(1427744-54-4)

Safety Data

• Hazardous Substances Data: 1427744-54-4(Hazardous Substances Data)

Upstream product

• 203798-34-9 3,6-diaminopyrazine-2,5-dicarboxylic acid 
• 226401-69-0 C₂₁H₂₂F₃NO₆S 
• 226401-67-8 C₂₆H₃₀F₃NO₈S 
• 828-27-3 4-Trifluoromethoxyphenol 
• 226396-63-0 1-(tert-butyl) 4-ethyl 4-[(4-fluorophenyl)sulfonyl]piperidine-1,4-dicarboxylate 
• 1427744-61-3 C₃₄H₃₈F₃N₇O₉S 
• 1427744-77-1 C₂₉H₂₉F₃N₆O₈S 
• 1427744-60-2 C₃₁H₃₃F₃N₆O₈S 
• 1427744-58-8 C₂₁H₂₂F₃NO₆S*C₂HF₃O₂ 

Relevant articles and documents

Design and synthesis of MMP inhibitors with appended fluorescent tags for imaging and visualization of matrix metalloproteinase enzymes

We describe the synthesis, MMP-2 and 9 potency, and in vitro evaluation of a series of α-sulfone hydroxmate MMP inhibitors conjugated to a series of dyes with different absorption/emission lamina maxima's that can be used to visualize tumors.

OPTICAL AGENTS FOR IMAGING AND VISUALIZATION OF MATRIX METALLOPROTEINASE ENZYMES

The invention relates generally to optical agents for biomedical applications including imaging, visualization, phototherapy and diagnostic monitoring of cells and tissue expressing MMPs and/or tissues associated with the expression of MMPs. In some embodiments, for example, optical agents of the present invention selectively bind to, or otherwise preferentially associate with, a target tissue expressing one or more MMPs, and function to couple electromagnetic radiation into and/or out of the target tissue, for example via optical absorption, fluorescence, scattering and/or optoacoustic processes.